137 related articles for article (PubMed ID: 20927697)
1. A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.
Schennach-Wolff R; Möller HJ; Jäger M; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Riedel M
Pharmacopsychiatry; 2010 Nov; 43(7):245-51. PubMed ID: 20927697
[TBL] [Abstract][Full Text] [Related]
2. Prediction of symptom remission in schizophrenia during inpatient treatment.
Jäger M; Riedel M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Bottlender R; Strauss A; Möller HJ
World J Biol Psychiatry; 2009; 10(4 Pt 2):426-34. PubMed ID: 17853260
[TBL] [Abstract][Full Text] [Related]
3. Obsessive-compulsive symptoms in schizophrenia: their relationship with clinical features and pharmacological treatment.
Nolfe G; Milano W; Zontini G; Petrella C; De Rosa M; Rundle-Smith S; Nolfe G
J Psychiatr Pract; 2010 Jul; 16(4):235-42. PubMed ID: 20644358
[TBL] [Abstract][Full Text] [Related]
4. Patient-based and clinician-based support for the remission criteria in schizophrenia.
Docherty JP; Bossie CA; Lachaux B; Bouhours P; Zhu Y; Lasser R; Gharabawi GM
Int Clin Psychopharmacol; 2007 Jan; 22(1):51-5. PubMed ID: 17159460
[TBL] [Abstract][Full Text] [Related]
5. Outcome in males with first-episode schizophrenia: 7-year follow-up.
Ceskova E; Prikryl R; Kasparek T
World J Biol Psychiatry; 2011 Feb; 12(1):66-72. PubMed ID: 21087079
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic reassessment and treatment response in schizophrenia.
Honer WG; Smith GN; MacEwan GW; Kopala L; Altman S; Yorkston N; Ehmann TS; Smith A; Lang M
J Clin Psychiatry; 1994 Dec; 55(12):528-32. PubMed ID: 7814346
[TBL] [Abstract][Full Text] [Related]
7. Definitions of response and remission in schizophrenia: recommendations for their use and their presentation.
Leucht S; Davis JM; Engel RR; Kissling W; Kane JM
Acta Psychiatr Scand Suppl; 2009; (438):7-14. PubMed ID: 19132961
[TBL] [Abstract][Full Text] [Related]
8. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
9. Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?
Schennach-Wolff R; Jäger M; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Klingberg S; Gastpar M; Seemüller F; Möller HJ; Riedel M
World J Biol Psychiatry; 2010 Aug; 11(5):729-38. PubMed ID: 20380620
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of treatment effects in schizophrenia.
Stroup TS
Am J Med; 2007 Apr; 120(4 Suppl 1):S26-31. PubMed ID: 17403379
[TBL] [Abstract][Full Text] [Related]
11. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
12. Evaluating characteristics of patient selection and dropout rates.
Keith SJ
J Clin Psychiatry; 2001; 62 Suppl 9():11-4; discussion 15-6. PubMed ID: 11379825
[TBL] [Abstract][Full Text] [Related]
13. Maintenance therapy and the natural course of schizophrenia.
Davis JM
J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):18-21. PubMed ID: 2865252
[TBL] [Abstract][Full Text] [Related]
14. Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics.
Wunderink L; Nienhuis FJ; Sytema S; Wiersma D
Schizophr Bull; 2007 May; 33(3):792-6. PubMed ID: 16894026
[TBL] [Abstract][Full Text] [Related]
15. Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.
Jäger M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Riedel M; Bottlender R; Strauss A; Möller HJ
Pharmacopsychiatry; 2008 Sep; 41(5):190-5. PubMed ID: 18763221
[TBL] [Abstract][Full Text] [Related]
16. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
Kao YC; Liu YP
Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
[TBL] [Abstract][Full Text] [Related]
17. Factors which can make patients difficult to treat.
Kane JM
Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650
[No Abstract] [Full Text] [Related]
18. [Problems in evaluating new antipsychotic drugs].
Fleischhacker WW
Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969
[TBL] [Abstract][Full Text] [Related]
19. Outcome of suicidal patients with schizophrenia: results from a naturalistic study.
Schennach-Wolff R; Jäger M; Seemüller F; Obermeier M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ; Riedel M
Acta Psychiatr Scand; 2010 May; 121(5):359-70. PubMed ID: 19878135
[TBL] [Abstract][Full Text] [Related]
20. Relapse prevention and recovery in the treatment of schizophrenia.
Schooler NR
J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
